• Citer

Corrigendum to “Clinical implications of body mass index (BMI) and weight in metastatic breast cancer (BC) patients treated with abemaciclib and endocrine therapy: A pooled individual patient level data analysis of MONARCH 2 and MONARCH 3 trials”

par Franzoi, Maria Alice;Ameye, Lieveke;Eiger, Daniel;Piccart-Gebhart, Martine ;Brandao, Marianna;Pondé, Noam;Desmedt, Christine ;Di Cosimo, S.;Paesmans, Marianne ;Caparica Bitton, Rafael ;Kotecki, Nuria;Lambertini, Matteo ;De Angelis, Claudia;Awada, Ahmad ;de Azambuja, Evandro
Référence Annals of oncology, 31, 10, page (1423)
Publication Publié, 2020-10-01

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Corrigendum to “Clinical implications of body mass index (BMI) and weight in metastatic breast cancer (BC) patients treated with abemaciclib and endocrine therapy: A pooled individual patient level data analysis of MONARCH 2 and MONARCH 3 trials”
Auteur:	Franzoi, Maria Alice; Ameye, Lieveke; Eiger, Daniel; Piccart-Gebhart, Martine; Brandao, Marianna; Pondé, Noam; Desmedt, Christine; Di Cosimo, S.; Paesmans, Marianne; Caparica Bitton, Rafael; Kotecki, Nuria; Lambertini, Matteo; De Angelis, Claudia; Awada, Ahmad; de Azambuja, Evandro
Informations sur la publication:	Annals of oncology, 31, 10, page (1423)
Statut de publication:	Publié, 2020-10-01
Sujet CREF:	Cancérologie
	Hématologie
Note générale:	SCOPUS: er.j
Langue:	Anglais
Identificateurs:	urn:issn:0923-7534
	info:doi/10.1016/j.annonc.2020.07.018
	info:pii/S0923753420399944
	info:scp/85089099855
	info:pmid/32750143